BJH - volume 7, issue Abstract Book BHS, january 2016
A. Theis , C. Crespo Sanchez , L. Plawny MD
BJH - volume 6, issue Abstract Book BHS, january 2015
C. Amicone , L. Plawny MD
BJH - volume 5, issue 1, march 2014
L. Duquenne MD, V. Schlesser PhD, Z. Jedidi MD, L. Plawny MD
Haemophilia C, also known as Rosenthal syndrome, is a rare disorder affecting essentially persons of Ashkenazi Jewish ascendancy. We report the case of a 79 year old patient without previous bleeding history, except for slight bruising, who presented with a severe retinal bleeding in the absence of trauma. Biology showed elevated activated partial thromboplastin time (77,7 seconds vs. normal range 30–36 seconds). Factor analysis showed isolated decreased Factor XI of 1%. No Factor XI inhibitor could be found. The patient was subsequently treated with Factor XI infusions which allowed a reduction of the bleeding and normal eyesight within four days. Spontaneous bleeding in old age is a rare inaugural sign of Factor XI deficiency, such episodes mostly occur after haemostatic challenge such as surgery or trauma leading to blood analysis and coagulation tests. Intraocular haemorrhage is an uncommon presentation of mild bleeding disorders.1–5
(BELG J HEMATOL;5(1):22–24)
Read moreBJH - 2013, issue BHS Abstractbook, january 2013
S. Ludovicy , C. Graux MD, PhD, A. Sonet MD, A. Charpentier , K. Chalabi , L. Plawny MD
BJH - 2013, issue BHS Abstractbook, january 2013
L. Plawny MD, A.V. Schettini
BJH - 2013, issue BHS Abstractbook, january 2013
N. Baicu , L. Plawny MD
BJH - volume 3, issue 3, september 2012
L. Plawny MD
Recent concerns about the safety of erythropoietin stimulating agents (ESAs) in cancer patients have led to a reformulation of the guidelines issued by NCCN, ASH/ASCO and ESMO. The goal of this review is to comment on various safety issues like mortality or thromboembolism or iron supplementation and to summarise the views of the three working groups concerning ESA treatment in cancer patients.
(BELG J HEMATOL 2012;3:88–94)
Read more
Top
